GE Healthcare Acquires PAA Laboratories GmbH
The company announced today that they have entered a definitive agreement to acquire PAA Laboratories. Full acquisition to be made by Q3 2011 granted regulatory approval.
View ArticleAbbott’s on Dow Jones Sustainability Indexes for Seventh Consecutive Year
Abbott scores highest percentage rating to date, makes list on Dow Jones Sustainability Indexes for seventh straight year.
View ArticleBristol-Myers Squibb Finalizes Acquisition of Amira Pharmaceuticals
Bristol-Myers Squibb formally finalizes acquisition of Amira, gains Amira's AM152 asset. BMS now enters fibrotic diseases market.
View ArticleGlaxoSmithKline & Amicus Begin Second Phase 3 Study of Amigal
Second Phase III study of Amigal is underway by GlaxoSmithKline and Amicus. The study is open-labeled and will have a duration of 18-months with the aim of collecting long-term data.
View ArticleBristol-Myers & Ambrx Announce Exclusive Research Rights Deal
Bristol-Myers Squibb & Ambrx announce exlusive research deal worth $24 million for Ambrx's FGF-21 protein data. Milestone and royalty payments from sales to Ambrx would happen in the future.
View ArticleAstraZeneca’s FASLODEX Receives First Approval in Japan
FASLODEX 500mg receives first regulatory approval in Japan and said that they expect a product launch by the end of this year, 2011.
View ArticleMerck Gets $175 Million from J&J Joint Venture Sale
Merck decides to sell off its joint venture with Johnson & Johnson to it and their affiliates. Merck retains rights to Pepcid brand, J&J acquires manufacturing plant in PA and rights to other...
View ArticleAstraZeneca Launches $200 Million Dollar Facility in China
AstraZeneca continues to expand its operations within China with a $200 million dollar manufacturing facility in the Jiangsu province. Company says that the new facility will allow them to meet rising...
View ArticleIDEXX Labs Acquires RADIL Reference Laboratory
IDEXX Laboratories, Inc. purchases RADIL Reference Laboratory from the University of Missouri. The University is paid $43 million dollars in cash for the research business.
View ArticleAbbott Laboratories (ABT) Announces Initiation of ESPRIT I
Abbott Laboratories announced its ESPRIT 1 clinical trial in up to ten different test sites in Europe and closed trading today at a new 52-week high amid moderately high volume.
View ArticleOriGene Technologies Acquires Beijing Zhongshan Golden Bridge Biotechnology
OriGene scoops up ZsBio, a pathology diagnostics company with more than 25 years of experience in China. The pathology market in China has recently experienced double-digit growth annually in China.
View ArticleOmnicell (OMCL) Completes MTS Medication Tech Bid
Omnicell finalizes acquisition of MTS Medication Technologies, Inc. which the company had previously announced on May 2nd, 2012 it intended to do.
View ArticleJazz Pharma (JAZZ) Wraps Up EUSA Pharma Acquisition
Jazz Pharma swoops in and scoops up EUSA Pharma for $680 million in cash and expects 2012 EPS to be readjusted to around $0.25 to $0.30.
View ArticleDraftfcb Healthcare Acquires Hudson Global, Retains Management Team
Interpublic Group subsidiary Draftfcb Healthcare scoops up Hudson Global and says acquisition creates a top 5 healthcare offering in the USA.
View ArticleAnti-Clotting Drug Approved by FDA
Eliquis, the anti-clotting drug by Bristol-Myers Squibb and Pfizer was approved on Friday by the U.S. Food and Drug Administration. The FDA approval had been long anticipated by many cardiologists and...
View ArticleJohnson & Johnson Diabetes Drug Gets Advisory Board Approval
On Thursday, a new drug being developed by Johnson & Johnson was given backing by an advisory panel that voted 10 to 5 in favor of recommending the drug to the U.S. Food and Drug Administration. If...
View ArticleFDA Approves New Use for Pfizer Vaccine
Pfizer received approval from the U.S. Food and Drug Administration on Friday to use Prevnar 13 in children and adolescents between the age of 6 and 17 to prevent Invasive Pneumococcal Disease. Prevnar...
View ArticleProfit at Merck Falls in Fourth Quarter
Merck, the pharmaceutical giant based in Whitehouse Station, New Jersey, announced that profits fell in the fourth quarter of 2012 by 7%. Company officials said that was due in part to sales of...
View ArticlePharmaceuticals Give Large Sums of Money to Physicians
Most patients are unaware that different pharmaceutical companies give doctors thousands of dollars for each patient that they enrol in experimental drug trials. Even though the motive’s of the...
View ArticleJustice Department Settles Online Pharmacy Probe with UPS
The U.S. Justice Department announced it had reached an agreement for $40 million Friday to settle charges against UPS that the giant shipping company had done business with Internet pharmacies that...
View Article
